Clinical Trial Update: Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures [Phase 2]

View source ↗

Summary

Phase 2 double-blind crossover trial evaluating fish oil (EPA and DHA) for intractable partial seizures has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Fish Oil (EPA and DHA) (EPA and DHA)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2014-01-10